Skip to main content
Clinical Trials/NCT00629044
NCT00629044CompletedNot Applicable

Etude du Polymorphysme génétique de la cholestérol 24S Hydroxylase et Des Teneurs en 24S hydroxycholestérol Chez Des Patients Atteints de Glaucome ou de dégénérescence Maculaire liée à l'âge.

Centre Hospitalier Universitaire Dijon1 site in 1 country320 target enrollmentStarted: November 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
320
Locations
1
Primary Endpoint
To know if cholesterol 24 S hydroxylase and 24 hydroxycholesterol are involve in Glaucoma and AMD

Study Overview

Brief Summary

The aim of this study is to assess the implicitement of the cholesterol 24 S hydroxylase gene and the 24 S hydroxycholesterol in glaucoma and in age related macular degeneration.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patient with Glaucoma
  • •Patient with AMD
  • •Healthy patient

Exclusion Criteria

  • •All patients who use any treatment in order to maintain in normal value their blood cholesterol

Arms & Interventions

G

Active Comparator

Intervention: Assessing the blood level of cholesterol 24 S Hydroxylase (Biological)

AMD

Active Comparator

Intervention: Assessing the blood level of cholesterol 24 S hydroxylase (Biological)

Healthy subjects

Active Comparator

Intervention: assessing the blood level of cholesterol 24 S hydroxylase (Biological)

Outcomes

Primary Outcomes

To know if cholesterol 24 S hydroxylase and 24 hydroxycholesterol are involve in Glaucoma and AMD

Time Frame: 2 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Study Sites (1)

Loading locations...

Similar Trials